Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Aug 7, 2009; 15(29): 3664-3669
Published online Aug 7, 2009. doi: 10.3748/wjg.15.3664
Published online Aug 7, 2009. doi: 10.3748/wjg.15.3664
Table 2 Survival rate of patients after sequential TACE-cryoablation or cryo-alone groups (%)
| Patients (n = 420) | Sequential group (n = 290) | Cryo-alone group (n = 130) | P | |
| Local recurrence | 17 | 11 | 24 | 0.001 |
| Survival rate | ||||
| 1-yr | 72 | 71 | 73 | 0.668 |
| 2-yr | 57 | 61 | 54 | 0.147 |
| 3-yr | 47 | 52 | 42 | 0.064 |
| 4-yr | 39 | 49 | 29 | 0.001 |
| 5-yr | 31 | 39 | 23 | 0.001 |
- Citation: Xu KC, Niu LZ, Zhou Q, Hu YZ, Guo DH, Liu ZP, Lan B, Mu F, Li YF, Zuo JS. Sequential use of transarterial chemoembolization and percutaneous cryosurgery for hepatocellular carcinoma. World J Gastroenterol 2009; 15(29): 3664-3669
- URL: https://www.wjgnet.com/1007-9327/full/v15/i29/3664.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.3664